Panel Discussion: Building Stronger Bridges Between Biotechs, Pharma & Investors

  • Share how biotechs can present data and strategy in ways that help investors and pharma make faster, more confident decisions, reducing risk on both sides
  • Highlight how pharma and investors can communicate expectations more clearly ensuring companies design studies and pipelines that are partner-ready